Adverse drug reaction to piperacillin-tazobactam mimicking Kounis syndrome in a pregnant lady diagnosed with pyelonephritis: a case report
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20254165Keywords:
Beta-lactam, Hypersensitivity, Naranjo, HartwigAbstract
Piperacillin-tazobactam is commonly used to treat severe infections during pregnancy, but it can also lead to life-threatening hypersensitivity reactions like Kounis syndrome (KS). A 25-year-old primigravida (G1P0) at 20 weeks' gestation presented with intractable vomiting, fever, and abdominal pain. She was admitted to the ICU with a diagnosis of pyelonephritis with septic shock, evidenced by hypotension (70/40 mmHg), tachycardia (114 bpm), leukocytosis (20,300/mm3), and elevated C-reactive protein (338.9 mg/l). She was initiated on IV fluids, noradrenaline, and empirical antibiotics, including piperacillin-tazobactam. Shortly after the first dose of piperacillin-tazobactam, the patient developed an acute, severe reaction characterized by hypertension (180/100 mmHg), tachycardia (130 bpm), hypoxia (89% SpO2), angioedema, wheezing, and chest pain with widespread ST-T abnormalities on ECG, suggesting a possible KS. The drug was immediately discontinued, and the patient was stabilized. A positive re-exposure on the following day with a single challenge dose confirmed the severe hypersensitivity and established causality. The drug was permanently withdrawn, and the patient was successfully managed with meropenem. This case suggests a life-threatening piperacillin–tazobactam hypersensitivity in pregnancy, with clinical features overlapping septic deterioration and possible KS.
Metrics
References
McGready R, Wuthiekanun V, Ashley EA, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, et al. Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings. Am J Trop Med Hyg. 2010;83(6):1322-9. DOI: https://doi.org/10.4269/ajtmh.2010.10-0332
Zhang H, Yang L. Adverse reactions of piperacillin: A literature review of case reports. Open Med. 2024;19(1):20240931. DOI: https://doi.org/10.1515/med-2024-0931
Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med. 2016;54(10):1545-59. DOI: https://doi.org/10.1515/cclm-2016-0010
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. DOI: https://doi.org/10.1038/clpt.1981.154
Petrova G, Stoimenova A, Dimitrova M, Kamusheva M, Petrova D, Georgiev O. Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy. SAGE Open Med. 2017;5:205031211769040. DOI: https://doi.org/10.1177/2050312117690404
Farkash E, Weintraub AY, Sergienko R, Wiznitzer A, Zlotnik A, Sheiner E. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):24-7. DOI: https://doi.org/10.1016/j.ejogrb.2012.01.024
Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2019;2019(11):CD000490. DOI: https://doi.org/10.1002/14651858.CD000490.pub4
Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014;210(3):219.e1-6. DOI: https://doi.org/10.1016/j.ajog.2013.10.006
Urinary Tract Infections in Pregnant Individuals. Obstet Gynecol. 2023;142(2):435-45. DOI: https://doi.org/10.1097/AOG.0000000000005269
Sheffield JS, Cunningham FG. Urinary tract infection in women. Obstet Gynecol. 2005;106(5 Pt 1):1085-92. DOI: https://doi.org/10.1097/01.AOG.0000185257.52328.a2
Molina-Muñoz JS, Cuadrado-Angulo J, Grillo-Ardila CF, Angel-Müller E, Cortés JA, Leal-Castro AL, et al. Consensus for the treatment of upper urinary tract infections during pregnancy. Rev Colomb Obstet Ginecol. 2023;74(1):37-52. DOI: https://doi.org/10.18597/rcog.3984
Corrales M, Corrales-Acosta E, Corrales-Riveros JG. Which Antibiotic for Urinary Tract Infections in Pregnancy? A Literature Review of International Guidelines. J Clin Med. 2022;11(23):7226. DOI: https://doi.org/10.3390/jcm11237226
Joint Formulary Committee, British National Formulary. Piperacillin with tazobactam J Drug j BNF content published by NICE. London: Pharmaceutical Press; 2020. Available at: https://bnf.nice.org.uk/drug/piperacillin-withtazobactam.html. Accessed on 12 October 2025.
Romano A, Di Fonso M, Viola M, Adesi FB, Venuti A. Selective hypersensitivity to piperacillin. Allergy. 2000;55(8):787. DOI: https://doi.org/10.1034/j.1398-9995.2000.00725.x
Casimir-Brown RS, Kennard L, Kayode OS, Siew LQC, Makris M, Tsilochristou O, et al. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis. J Allergy Clin Immunol Pract. 2021;9(5):2001-9. DOI: https://doi.org/10.1016/j.jaip.2020.12.051
Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol. 2006;110(1):7-14. DOI: https://doi.org/10.1016/j.ijcard.2005.08.007
Ridella M, Bagdure S, Nugent K, Cevik C. Kounis syndrome following beta-lactam antibiotic use: review of literature. Inflamm Allergy Drug Targets. 2009;8(1):11-6. DOI: https://doi.org/10.2174/187152809787582462
Calogiuri GF, Nettis E, Di Leo E, Vacca A, Ferrannini A, Kounis NG. Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report. Int J Cardiol. 2012;155(3):e42-4. DOI: https://doi.org/10.1016/j.ijcard.2011.07.049
Downloads
Published
How to Cite
Issue
Section
